Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights

Area of Science:

• Oncology
• Pharmacology
• Natural Product Chemistry

Background:

• Existing hepatocellular carcinoma (HCC) treatments have limitations.
• Carcinogenesis involves complex cell signaling pathways like proliferation, invasion, and angiogenesis.
• Natural products from food and medicinal plants are a rich source for novel therapeutic discovery.

Purpose of the Study:

• To review curative molecules for hepatocellular carcinoma (HCC).
• To explore the potential of biomolecules targeting specific cancer pathways.
• To highlight natural compounds with characterized anti-cancer mechanisms and targets.

Main Methods:

• Literature review of existing HCC curative molecules.
• Analysis of cell signaling mechanisms in carcinogenesis.
• Focus on biomolecules with characterized molecular targets and anti-cancer mechanisms.
• Consideration of quantitative structure-activity relationship (QSAR) studies.

Main Results:

• Natural biomolecules show promise as alternative HCC therapies.
• These compounds often possess superior biosafety, antioxidant, and anti-inflammatory properties.
• Biomolecules can serve as templates for developing more effective and bioavailable drugs.

Conclusions:

• Natural biomolecules represent a promising avenue for developing novel hepatocellular carcinoma (HCC) treatments.
• Targeting specific cancer pathways with well-characterized natural compounds can enhance therapeutic efficacy.
• Further research into biomolecules, aided by QSAR, can optimize drug development for HCC.